galantamine has been researched along with Bradykinesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, M; Mizuguchi, Y; Morimoto, T; Ohno, Y; Shimizu, S; Sobue, A | 1 |
| Andersen, MB; Fink-Jensen, A; Werge, T | 1 |
2 other study(ies) available for galantamine and Bradykinesia
| Article | Year |
|---|---|
Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice.
Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Interactions; Galantamine; Haloperidol; Hypokinesia; Indans; Male; Mice, Inbred Strains; Nootropic Agents; Piperidines; Receptor, Serotonin, 5-HT1A; Receptors, Muscarinic; Serotonin Agents | 2015 |
The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.
Topics: Animals; Arousal; Behavior, Animal; Cebus; Cholinesterase Inhibitors; Dextroamphetamine; Dyskinesia, Drug-Induced; Dystonia; Galantamine; Hypokinesia; Locomotion; Male; Psychomotor Agitation; Psychoses, Substance-Induced; Sleep Stages; Stereotyped Behavior; Time Factors | 2007 |